Advertisement

Child's Nervous System

, Volume 35, Issue 10, pp 1727–1739 | Cite as

Chiari I malformation in defined genetic syndromes in children: are there common pathways?

  • Veronica SalettiEmail author
  • Ilaria Viganò
  • Giulia Melloni
  • Chiara Pantaleoni
  • Ignazio Gaspare Vetrano
  • Laura Grazia Valentini
Special Annual Issue

Abstract

Purpose

Chiari malformation type I (CMI) is a common pediatric neurologic anomaly that can be associated with a variety of genetic disorders; however, it is not always clear whether the observed associations are real or random. The knowledge of the real associations could provide useful guidance to clinicians. Furthermore, it could be of help to better understand the still unknown genetic etiology of CMI.

Methods

With the aim of implementing such insights, we retrospectively reviewed clinical, neuroradiological, and genetic data of patients harboring CMI evaluated at the Child Neurology Unit of our institution between January 2008 and December 2018.

Results

The cohort consists of 205 patients (111 males and 94 females), with a mean age at diagnosis of 6.3 years (range 0–18 years). 188 patients completed an average follow-up period of 5.2 years (range one month–18 years). Mean age at last assessment was 11.4 years (range nine months–23 years). 127 (62%) children have been classified as syndromic due to the presence of neurodevelopmental disorders, phenotypic anomalies, or malformations. Among syndromic CMI children, a molecular diagnosis was identified in 35/127 (27.6%) (20 males and 15 females). The most common diagnoses were syndromic craniosynostosis in 8/35 children (22.9%), among which sevenare FGFR-related and one ERF-related craniosynostosis; disorders of the RAS/MAPK pathway, termed RASopathies or RAS/MAPK syndromes in 9/35 (25.7%); disorders of the PTEN-PI3K/AKT signal transduction cascade, termed PTENopathies in 3/35 children (8.6%); and chromosomal rearrangements in 6/35 patients (17.1%), two of whom with del16p11.2.

Conclusions

We polarized our attention on the defined genetic diagnoses focusing not only on the phenotypic hallmarks but also on the phenotypic overlapping features. In addition, we discussed the pathophysiological mechanisms leading to progressive cerebellar ectopia and the involved molecular pathways. Along with the recent literature evidence, we suppose that interactions between FGFR and RAS/MAPK pathway and between RAS/MAPK and PTEN-PI3K/AKT pathways could explain some phenotypic overlapping features and could have a significant role in the pathogenesis of CMI.

Keywords

Chiari I malformation Genetic syndromes RASopathies Craniosynostosis PTENopathies Chromosomal rearrangements 

Notes

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

References

  1. 1.
    Addissie YA, Kotecha U, Hart RA, Martinez AF, Kruszka P, Muenke M (2015) Craniosynostosis and Noonan syndrome with KRAS mutations: expanding the phenotype with a case report and review of the literature. Am J Med Genet A 167A(11):2657–2663.  https://doi.org/10.1002/ajmg.a.37259 CrossRefPubMedGoogle Scholar
  2. 2.
    Aghakhanyan G, Bonanni P, Randazzo G, Nappi S, Tessarotto F, De Martin L, Frijia F, De Marchi D, De Masi F, Kuppers B, Lombardo F, Caramella D, Montanaro D (2016) From cortical and subcortical grey matter abnormalities to neurobehavioral phenotype of Angelman syndrome: a voxel-based morphometry study. PLoS One 11(9):e0162817.  https://doi.org/10.1371/journal.pone.0162817 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Aoki Y, Niihori T, Inoue S, Matsubara Y (2016) Recent advances in RASopathies. J Hum Genet 61:33–39.  https://doi.org/10.1038/jhg.2015.114 CrossRefPubMedGoogle Scholar
  4. 4.
    Bolognese PA, Brodbelt A, Bloom AB, Kula RW (2019) Chiari I malformation: opinions on diagnostic trends and controversies from a panel of 63 international experts. World Neurosurg.  https://doi.org/10.1016/j.wneu.2019.05.098
  5. 5.
    Caldarelli M, Novegno F, Di Rocco C (2009) A late complication of CSF shunting: acquired Chiari I malformation. Childs Nerv Syst 25(4):443–452.  https://doi.org/10.1007/s00381-008-0760-z CrossRefPubMedGoogle Scholar
  6. 6.
    Ciaccio C, Saletti V, D'Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D (2018) Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet.  https://doi.org/10.1016/j.ejmg.2018.12.001
  7. 7.
    Cinalli G, Spennato P, Sainte-Rose C, Arnaud E, Aliberti F, Brunelle F, Cianciulli E, Renier D (2005) Chiari malformation in craniosynostosis. Childs Nerv Syst 21(10):889–901.  https://doi.org/10.1007/s00381-004-1115-z CrossRefGoogle Scholar
  8. 8.
    Ciprero KL, Clayton-Smith J, Donnai D, Zimmerman RA, Zackai EH, Ming JE (2005) Symptomatic Chiari I malformation in Kabuki syndrome. Am J Med Genet A 132A(3):273–275.  https://doi.org/10.1002/ajmg.a.30387 CrossRefPubMedGoogle Scholar
  9. 9.
    de Souza RM, Zador Z, Frim DM (2011) Chiari malformation type I: related conditions. Neurol Res 33(3):278–284.  https://doi.org/10.1179/016164111X12962202723922 CrossRefGoogle Scholar
  10. 10.
    Di Rocco C, Velardi F (2003) Acquired Chiari type I malformation managed by supratentorial cranial enlargement. Childs Nerv Syst 19(12):800–807.  https://doi.org/10.1007/s00381-003-0837-7 CrossRefPubMedGoogle Scholar
  11. 11.
    Di Rocco C, Frassanito P, Massimi L, Peraio S (2011) Hydrocephalus and Chiari type I malformation. Childs Nerv Syst 27(10):1653–1664.  https://doi.org/10.1007/s00381-011-1545-3 CrossRefGoogle Scholar
  12. 12.
    Ejarque I, Millán-Salvador JM, Oltra S, Pesudo-Martínez JV, Beneyto M, Pérez-Aytés A (2015) Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway. Rev Neurol 60(9):408–412PubMedGoogle Scholar
  13. 13.
    Elster AD, Chen MY (1992) Chiari I malformations: clinical and radiologic reappraisal. Radiology 183:347–353.  https://doi.org/10.1148/radiology.183.2.1561334 CrossRefPubMedGoogle Scholar
  14. 14.
    Fearon JA, Rhodes J (2009) Pfeiffer syndrome: a treatment evaluation. Plast Reconstr Surg 123:1560–1569.  https://doi.org/10.1097/PRS.0b013e3181a2057e CrossRefPubMedGoogle Scholar
  15. 15.
    Glass GE, O'Hara J, Canham N, Cilliers D, Dunaway D, Fenwick AL, Jeelani NO, Johnson D, Lester T, Lord H, Morton JEV, Nishikawa H, Noons P, Schwiebert K, Shipster C, Taylor-Beadling A, Twigg SRF, Vasudevan P, Wall SA, Wilkie AOM, Wilson LC (2019) ERF-related craniosynostosis: the phenotypic and developmental profile of a new craniosynostosis syndrome. Am J Med Genet A 179(4):615–627.  https://doi.org/10.1002/ajmg.a.61073 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Glenn C, Cheema AA, Safavi-Abbasi S, Gross NL, Martin MD, Mapstone TB (2015) Spinal cord detethering in children with tethered cord syndrome and Chiari type 1 malformations. J Clin Neurosci 22(11):1749–1752.  https://doi.org/10.1016/j.jocn.2015.05.023 CrossRefPubMedGoogle Scholar
  17. 17.
    Goos JAC, Mathijssen IMJ (2019) Genetic causes of craniosynostosis: an update. Mol Syndromol 10(1–2):6–23.  https://doi.org/10.1159/000492266 CrossRefPubMedGoogle Scholar
  18. 18.
    Gripp KW, Hopkins E, Doyle D, Dobyns WB (2010) High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities. Am J Med Genet A 152A(5):1161–1168.  https://doi.org/10.1002/ajmg.a.33391 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gripp KW, Hopkins E, Sol-Church K, Stabley DL, Axelrad ME, Doyle D, Dobyns WB, Hudson C, Johnson J, Tenconi R, Graham GE, Sousa AB, Heller R, Piccione M, Corsello G, Herman GE, Tartaglia M, Lin AE (2011) Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C. Am J Med Genet A 155A(4):706–716.  https://doi.org/10.1002/ajmg.a.33884 CrossRefPubMedGoogle Scholar
  20. 20.
    Hansen-Kiss E, Beinkampen S, Adler B, Frazier T, Prior T, Erdman S, Eng C, Herman G (2017) A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children. J Med Genet 54(7):471–478.  https://doi.org/10.1136/jmedgenet-2016-104484 CrossRefPubMedGoogle Scholar
  21. 21.
    Henderson FC Sr, Austin C, Benzel E, Bolognese P, Ellenbogen R, Francomano CA, Ireton C, Klinge P, Koby M, Long D, Patel S, Singman EL, Voermans NC (2017) Neurological and spinal manifestations of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 175(1):195–211.  https://doi.org/10.1002/ajmg.c.31549 CrossRefPubMedGoogle Scholar
  22. 22.
    Holder-Espinasse M, Winter RM (2003) Type 1 Arnold-Chiari malformation and Noonan syndrome: a new diagnostic feature? Clin Dysmorphol 12:275.  https://doi.org/10.1097/01.mcd.0000081505.97834.0a CrossRefPubMedGoogle Scholar
  23. 23.
    Hukki A, Koljonen V, Karppinen A, Valanne L, Leikola J (2012) Brain anomalies in 121 children with non-syndromic single suture craniosynostosis by MR imaging. Eur J Paediatr Neurol 16(6):671–675.  https://doi.org/10.1016/j.ejpn.2012.04.003 CrossRefPubMedGoogle Scholar
  24. 24.
    Kahn EN, Muraszko KM, Maher CO (2015) Prevalence of Chiari I malformation and syringomyelia. Neurosurg Clin N Am 26:501–507.  https://doi.org/10.1016/j.nec.2015.06.006 CrossRefPubMedGoogle Scholar
  25. 25.
    Keh YS, Abernethy L, Pettorini B (2013) Association between Noonan syndrome and Chiari I malformation: a case-based update. Childs Nerv Syst 29(5):749–752.  https://doi.org/10.1007/s00381-012-2000-9 CrossRefPubMedGoogle Scholar
  26. 26.
    Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, Burgelin I, Stef M, Tang B, Eden OB, O'Sullivan J, De Sandre-Giovannoli A, Reardon W, Brewer C, Bennett C, Quarell O, M'Cann E, Donnai D, Stewart F, Hennekam R, Cavé H, Verloes A, Philip N, Lacombe D, Levy N, Arveiler B, Black G (2006) Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 43(5):401–405.  https://doi.org/10.1136/jmg.2005.040352 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kratz CP, Zampino G, Kriek M, Kant SG, Leoni C, Pantaleoni F, Oudesluys-Murphy AM, Di Rocco C, Kloska SP, Tartaglia M, Zenker M (2009) Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations. Am J Med Genet A 149A(5):1036–1040.  https://doi.org/10.1002/ajmg.a.32786 CrossRefPubMedGoogle Scholar
  28. 28.
    Lattanzi W, Barba M, Di Pietro L, Boyadjiev SA (2017) Genetic advances in craniosynostosis. Am J Med Genet A 173(5):1406–1429.  https://doi.org/10.1002/ajmg.a.38159 CrossRefPubMedGoogle Scholar
  29. 29.
    Loukas M, Shayota BJ, Oelhafen K, Miller JH, Chern JJ, Tubbs RS, Oakes WJ (2011) Associated disorders of Chiari type I malformations: a review. Neurosurg Focus 31(3):E3.  https://doi.org/10.3171/2011.6.FOCUS11112 CrossRefPubMedGoogle Scholar
  30. 30.
    Markunas CA, Lock E, Soldano K, Cope H, Ding CK, Enterline DS, Grant G, Fuchs H, Ashley-Koch AE, Gregory SG (2014) Identification of Chiari Type I malformation subtypes using whole genome expression profiles and cranial base morphometrics. BMC Med Genomics 7:39.  https://doi.org/10.1186/1755-8794-7-39 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Mathijssen IMJ (2015) Guideline for care of patients with the diagnoses of craniosynostosis: Working Group on Craniosynostosis. J Craniofac Surg 26(6):1735–1807.  https://doi.org/10.1097/SCS.0000000000002016 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    McGaughran J, Aftimos S, Jefferies C, Winship I (2001) Clinical phenotypes of nine cases of Kabuki syndrome from New Zealand. Clin Dysmorphol 10(4):257–262CrossRefPubMedGoogle Scholar
  33. 33.
    Mester J, Eng C (2013) When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C Semin Med Genet 163C(2):114–121.  https://doi.org/10.1002/ajmg.c.31364 CrossRefPubMedGoogle Scholar
  34. 34.
    Milhorat TH, Nishikawa M, Kula RW, Dlugacz YD (2010) Mechanisms of cerebellar tonsil herniation in patients with Chiari malformations as guide to clinical management. Acta Neurochir 152(7):1117–1127.  https://doi.org/10.1007/s00701-010-0636-3 CrossRefGoogle Scholar
  35. 35.
    Miraglia E, Fabbrini G, Di Biasi C, Iacovino C, Ferrazzano G, Gualdi G, Calvieri S, Giustini S (2016) Chiari type 1 malformation in Neurofibromatosis type 1: experience of a center and review of the literature. Clin Ter 167(1):e6–e10.  https://doi.org/10.7417/T.2016.1912 CrossRefPubMedGoogle Scholar
  36. 36.
    Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, Lev D, Kramer N, Hopkins E, Graham JM Jr, Dobyns WB (2012) Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 158A:269–291.  https://doi.org/10.1002/ajmg.a.34402 CrossRefPubMedGoogle Scholar
  37. 37.
    Mirzaa GM, Rivière JB, Dobyns WB (2013) Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 163C(2):122–130.  https://doi.org/10.1002/ajmg.c.31361 CrossRefPubMedGoogle Scholar
  38. 38.
    Muzumdar D, Ventureyra EC (2006) Tonsillar herniation and cervical syringomyelia in association with posterior fossa tumors in children: a case-based update. Childs Nerv Syst 22(5):454–459.  https://doi.org/10.1007/s00381-005-0027-x CrossRefPubMedGoogle Scholar
  39. 39.
    Nishikawa M, Sakamoto H, Hakuba A, Nakanishi N, Inoue Y (1997) Pathogenesis of Chiari malformation: a morphometric study of the posterior cranial fossa. J Neurosurg 86(1):40–47.  https://doi.org/10.3171/jns.1997.86.1.0040 CrossRefPubMedGoogle Scholar
  40. 40.
    Owen JP, Bukshpun P, Pojman N, Thieu T, Chen Q, Lee J, D’Angelo D, Glenn OA, Hunter JV, Berman JI, Roberts TP, Buckner R, Nagarajan SS, Mukherjee P, Sherr EH (2018) Brain MR imaging findings and associated outcomes in carriers of the reciprocal copy number variation at 16p11.2. Radiology 286(1):217–226.  https://doi.org/10.1148/radiol.2017162934 CrossRefPubMedGoogle Scholar
  41. 41.
    Poretti A, Ashmawy R, Garzon-Muvdi T, Jallo GI, Huisman TA, Raybaud C (2016) Chiari type 1 deformity in children: pathogenetic, clinical, neuroimaging, and management aspects. Neuropediatrics 47(5):293–307.  https://doi.org/10.1055/s-0036-1584563 CrossRefPubMedGoogle Scholar
  42. 42.
    Pozetti M, Belsuzarri TA, Belsuzarri NC, Seixas NB, Araujo JF (2016) Neurofibromatosis type 1 and Chiari type 1 malformation: a case report and literature review of a rare association. Surg Neurol Int 7(Suppl 16):S469–S472PubMedPubMedCentralGoogle Scholar
  43. 43.
    Riffaud L, Moughty C, Henaux PL, Haegelen C, Morandi X (2008) Acquired Chiari I malformation and syringomyelia after valveless lumboperitoneal shunt in infancy. Pediatr Neurosurg 44(3):229–233.  https://doi.org/10.1159/000121381 CrossRefPubMedGoogle Scholar
  44. 44.
    Rothenbuhler A, Fadel N, Debza Y, Bacchetta J, Diallo MT, Adamsbaum C, Linglart A, Di Rocco F (2019) High incidence of cranial synostosis and Chiari I malformation in children with X-linked hypophosphatemic rickets (XLHR). J Bone Miner Res 34(3):490–496.  https://doi.org/10.1002/jbmr.3614 CrossRefGoogle Scholar
  45. 45.
    Saletti V, Esposito S, Frittoli M, Valentini LG, Chiapparini L, Bulgheroni S, Riva D (2011) Neurological pictures in paediatric Chiari I malformation. Neurol Sci 32:295–298.  https://doi.org/10.1007/s10072-011-0744-8 CrossRefGoogle Scholar
  46. 46.
    Saletti V, Esposito S, Maccaro A, Giglio S, Valentini LG, Chiapparini L (2017) Chiari I malformation in a child with PTEN hamartoma tumor syndrome: association or coincidence? Eur J Med Genet 60(5):261–264.  https://doi.org/10.1016/j.ejmg.2017.03.002 CrossRefPubMedGoogle Scholar
  47. 47.
    Schijman E (2004) History, anatomic forms, and pathogenesis of Chiari I malformations. Childs Nerv Syst 20(5):323–328.  https://doi.org/10.1007/s00381-003-0878-y CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Speer MC, George TM, Enterline DS, Franklin A, Wolpert CM, Milhorat TH (2000) A genetic hypothesis for Chiari I malformation with or without syringomyelia. Neurosurg Focus 8(3):E12CrossRefPubMedGoogle Scholar
  49. 49.
    Steinman KJ, Spence SJ, Ramocki MB, Proud MB, Kessler SK, Marco EJ, Green Snyder L, D'Angelo D, Chen Q, Chung WK, Sherr EH, Simons VIP Consortium (2016) 16p11.2 deletion and duplication: characterizing neurologic phenotypes in a large clinically ascertained cohort. Am J Med Genet A 170(11):2943–2955.  https://doi.org/10.1002/ajmg.a.37820 CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Szewka AJ, Walsh LE, Boaz JC, Carvalho KS, Golomb MR (2006) Chiari in the family: inheritance of the Chiari I malformation. Pediatr Neurol 34(6):481–485.  https://doi.org/10.1016/j.pediatrneurol.2005.09.008 CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Takenouchi T, Sakamoto Y, Miwa T, Torii C, Kosaki R, Kishi K, Takahashi T, Kosaki K (2014) Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways. Am J Med Genet A 164:2869–2872.  https://doi.org/10.1002/ajmg.a.36705 CrossRefGoogle Scholar
  52. 52.
    Tubbs RS, Oakes WJ (2003) Costello syndrome and Chiari I malformation: apropos of a case with a review of the literature regarding a potential association. J Child Neurol 18(7):496–498.  https://doi.org/10.1177/08830738030180070801 CrossRefPubMedGoogle Scholar
  53. 53.
    Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ (2004) Chiari I malformation and neurofibromatosis type 1. Pediatr Neurol 30(4):278–280.  https://doi.org/10.1016/j.pediatrneurol.2003.09.013 CrossRefPubMedGoogle Scholar
  54. 54.
    Tubbs RS, Webb D, Abdullatif H, Conklin M, Doyle S, Oakes WJ (2004) Posterior cranial fossa volume in patients with rickets: insights into the increased occurrence of Chiari I malformation in metabolic bone disease. Neurosurgery 55:380–384.  https://doi.org/10.1227/01.neu.0000129547.30778.b7 CrossRefPubMedGoogle Scholar
  55. 55.
    Tubbs RS, Lyerly MJ, Loukas M, Shoja MM, Oakes WJ (2007) The pediatric Chiari I malformation: a review. Childs Nerv Syst 23(11):1239–1250.  https://doi.org/10.1007/s00381-007-0428-0 CrossRefPubMedGoogle Scholar
  56. 56.
    Tubbs RS, Beckman J, Naftel RP, Chern JJ, Wellons JC 3rd, Rozzelle CJ, Blount JP, Oakes WJ (2011) Institutional experience with 500 cases of surgically treated pediatric Chiari malformation type I. J Neurosurg Pediatr 7(3):248–256.  https://doi.org/10.3171/2010.12.PEDS10379 CrossRefGoogle Scholar
  57. 57.
    Twigg SR, Wilkie AO (2015) A genetic-pathophysiological framework for craniosynostosis. Am J Hum Genet 97(3):359–377.  https://doi.org/10.1016/j.ajhg.2015.07.006 CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Twigg SR, Vorgia E, McGowan SJ, Peraki I, Fenwick AL, Sharma VP, Allegra M, Zaragkoulias A, Sadighi Akha E, Knight SJ, Lord H, Lester T, Izatt L, Lampe AK, Mohammed SN, Stewart FJ, Verloes A, Wilson LC, Healy C, Sharpe PT, Hammond P, Hughes J, Taylor S, Johnson D, Wall SA, Mavrothalassitis G, Wilkie AO (2013) Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet 45(3):308–313.  https://doi.org/10.1038/ng.2539 CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Udayakumaran S, Onyia CU (2015) Beckwith-Wiedemann syndrome and Chiari I malformation--a case-based review of central nervous system involvement in hemihypertrophy syndromes. Childs Nerv Syst 31(5):637–641.  https://doi.org/10.1007/s00381-015-2642-5 CrossRefPubMedGoogle Scholar
  60. 60.
    Ueda K, Yaoita M, Niihori T, Aoki Y, Okamoto N (2017) Craniosynostosis in patients with RASopathies: accumulating clinical evidence for expanding the phenotype. Am J Med Genet A 173:2346–2352.  https://doi.org/10.1002/ajmg.a.38337 CrossRefPubMedGoogle Scholar
  61. 61.
    Urbizu A, Poca MA, Vidal X, Rovira A, Sahuquillo J, Macaya A (2014) MRI-based morphometric analysis of posterior cranial fossa in the diagnosis of chiari malformation type I. J Neuroimaging 24(3):250–256.  https://doi.org/10.1111/jon.12007 CrossRefPubMedGoogle Scholar
  62. 62.
    Wang J, Alotaibi NM, Samuel N, Ibrahim GM, Fallah A, Cusimano MD (2017) Acquired Chiari malformation and Syringomyelia secondary to space-occupying lesions: a systematic eview. World Neurosurg 98:800–808.e2.  https://doi.org/10.1016/j.wneu.2016.11.080 CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    White SM, Graham JM Jr, Kerr B, Gripp K, Weksberg R, Cytrynbaum C, Reeder JL, Stewart FJ, Edwards M, Wilson M, Bankier A (2005) The adult phenotype in Costello syndrome. Am J Med Genet A 136(2):128–135.  https://doi.org/10.1002/ajmg.a.30747 CrossRefPubMedGoogle Scholar
  64. 64.
    Yang C, Deng X, Yang J, Xu Y (2019) Shunt dependency syndrome and acquired Chiari malformation secondary to cerebrospinal fluid diversion procedures: a 9-year longitudinal observation. Childs Nerv Syst 5(4):707–711.  https://doi.org/10.1007/s00381-018-4014-4 CrossRefGoogle Scholar
  65. 65.
    Yehia L, Eng C (2018) 65 YEARS OF THE DOUBLE HELIX: one gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine. Endocr Relat Cancer 25(8):T121–T140.  https://doi.org/10.1530/ERC-18-0162 CrossRefPubMedGoogle Scholar
  66. 66.
    Yoon G, Rosenberg J, Blaser S, Rauen KA (2007) Neurological complications of cardio-facio-cutaneous syndrome. Dev Med Child Neurol 49(12):894–899.  https://doi.org/10.1111/j.1469-8749.2007.00894.x CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Developmental Neurology UnitFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly
  2. 2.Department of NeurosurgeryFondazione IRCCS Istituto Neurologico Carlo BestaMilanItaly

Personalised recommendations